Figure 5.
Percentages of subjects with hSBA titers ≥1:4 at 6 to 10 y after primary vaccination with MenACWY-TT, MenC-CRM, or MenACWY-PS (adapted ATP cohort) (a) serogroup A, (b) serogroup C, (c) serogroup W, and (d) serogroup Y.
Percentages of subjects with hSBA titers ≥1:4 at 6 to 10 y after primary vaccination with MenACWY-TT, MenC-CRM, or MenACWY-PS (adapted ATP cohort) (a) serogroup A, (b) serogroup C, (c) serogroup W, and (d) serogroup Y.